ATAI Life Sciences N.V.
CIK: 0001840904
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CMPS
COMPASS Pathways plc
10% Owner
Discretionary Trading P&L
Holdings
About ATAI Life Sciences N.V.
ATAI Life Sciences N.V. (SEC CIK 0001840904) files insider reports with the SEC as 10% Owner of COMPASS Pathways plc (CMPS).
Signal8 holds 1 ownership filing by ATAI Life Sciences N.V., a Form 4, filed on Sep 27, 2024. Those filings report 1 transaction, the latest on Sep 26, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on ATAI Life Sciences N.V.'s filings is in BERLIN, 2M.
Recent filings by ATAI Life Sciences N.V.
- Sep 26, 2024: Open-market sale of CMPS shares (Form 4, code S).
Other insiders filing for COMPASS Pathways plc (CMPS)
- Nath Kabir, Chief Executive Officer
- Karydas Daphne, Director
- SANTINI GINO, Director
- Gover Justin D., Director
- JONAS JEFFREY M, Director
- Riley Wayne Joseph, Director